360 related articles for article (PubMed ID: 32917155)
1. Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom.
Bayoumy AB; van Liere ELSA; Simsek M; Warner B; Loganayagam A; Sanderson JD; Anderson S; Nolan J; de Boer NK; Mulder CJJ; Ansari A
BMC Gastroenterol; 2020 Sep; 20(1):296. PubMed ID: 32917155
[TBL] [Abstract][Full Text] [Related]
2. Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.
Musumba CO
Aliment Pharmacol Ther; 2013 Nov; 38(9):1025-37. PubMed ID: 24099468
[TBL] [Abstract][Full Text] [Related]
3. The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study.
Gensmyr-Singer H; Werner M; Karling P
Therap Adv Gastroenterol; 2024; 17():17562848241228064. PubMed ID: 38384282
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine.
Bayoumy AB; Mulder CJJ; Loganayagam A; Sanderson JD; Anderson S; Boekema PJ; Derijks LJJ; Ansari AR
Ther Drug Monit; 2021 Oct; 43(5):617-623. PubMed ID: 34521801
[TBL] [Abstract][Full Text] [Related]
5. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.
Derijks LJ; de Jong DJ; Gilissen LP; Engels LG; Hooymans PM; Jansen JB; Mulder CJ
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):63-7. PubMed ID: 12544696
[TBL] [Abstract][Full Text] [Related]
6. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.
Dubinsky MC; Feldman EJ; Abreu MT; Targan SR; Vasiliauskas EA
Am J Gastroenterol; 2003 May; 98(5):1058-63. PubMed ID: 12809828
[TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatment.
van Asseldonk DP; Seinen ML; de Boer NK; van Bodegraven AA; Mulder CJ
J Crohns Colitis; 2012 Feb; 6(1):95-101. PubMed ID: 22261533
[TBL] [Abstract][Full Text] [Related]
8. On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients.
de Boer NK; Derijks LJ; Gilissen LP; Hommes DW; Engels LG; de-Boer SY; den Hartog G; Hooymans PM; Mäkelburg AB; Westerveld BD; Naber AH; Mulder CJ; de Jong DJ
World J Gastroenterol; 2005 Sep; 11(35):5540-4. PubMed ID: 16222751
[TBL] [Abstract][Full Text] [Related]
9. Thioguanine is Effective as Maintenance Therapy for Inflammatory Bowel Disease: A Prospective Multicentre Registry Study.
Simsek M; Schepers F; Kaplan S; van Asseldonk D; van Boeckel P; Boekema P; Dijkstra G; Fidder H; Gisbertz I; Hoentjen F; Jharap B; Kubben F; de Leest M; Meijssen M; Petrak A; van de Poel E; Russel M; van Bodegraven AA; Mulder CJJ; de Boer N
J Crohns Colitis; 2023 Jun; 17(6):933-942. PubMed ID: 36702552
[TBL] [Abstract][Full Text] [Related]
10. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
[TBL] [Abstract][Full Text] [Related]
11. Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.
Seinen ML; van Asseldonk DP; de Boer NK; Bouma G; van Nieuwkerk CM; Mulder CJ; Bloemena E; van Bodegraven AA
Inflamm Bowel Dis; 2017 Mar; 23(3):448-452. PubMed ID: 28151736
[TBL] [Abstract][Full Text] [Related]
12. Further experience with the use of 6-thioguanine in patients with Crohn's disease.
Ansari A; Elliott T; Fong F; Arenas-Hernandez M; Rottenberg G; Portmann B; Lucas S; Marinaki A; Sanderson J
Inflamm Bowel Dis; 2008 Oct; 14(10):1399-405. PubMed ID: 18521912
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease.
Ansari A; Elliott T; Baburajan B; Mayhead P; O'Donohue J; Chocair P; Sanderson J; Duley J
Aliment Pharmacol Ther; 2008 Sep; 28(6):734-41. PubMed ID: 19145729
[TBL] [Abstract][Full Text] [Related]
14. Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series.
Bayoumy AB; Jagt JZ; van Wering HM; de Ridder L; Hummel T; Wolters VM; Stapelbroek J; Benninga MA; Mulder CJJ; de Boer NKH; de Meij TGJ;
J Pediatr Gastroenterol Nutr; 2022 Dec; 75(6):e111-e115. PubMed ID: 36136124
[TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy.
Jansen FM; Smits LJT; Thomas PWA; de Jong DJ; Kreijne JE; van Dop WA; den Broeder N; Hoentjen F
Dig Dis Sci; 2023 Jul; 68(7):2936-2945. PubMed ID: 37131100
[TBL] [Abstract][Full Text] [Related]
17. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients.
Dubinsky MC; Vasiliauskas EA; Singh H; Abreu MT; Papadakis KA; Tran T; Martin P; Vierling JM; Geller SA; Targan SR; Poordad FF
Gastroenterology; 2003 Aug; 125(2):298-303. PubMed ID: 12891528
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
Hoentjen F; Seinen ML; Hanauer SB; de Boer NK; Rubin DT; Bouma G; Harrell LE; van Bodegraven AA
Inflamm Bowel Dis; 2013 Feb; 19(2):363-9. PubMed ID: 22605661
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of thioguanine as a maintenance therapy of inflammatory bowel disease: Systematic review, meta-analysis and meta-regression.
Jena A; Neelam PB; Telaprolu H; Mangipudi UK; Dutta U; Sebastian S; Sharma V
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102155. PubMed ID: 37301255
[TBL] [Abstract][Full Text] [Related]
20. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B
Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
